Q Brands pursues a long-biased investment style which is systematic, investing globally in highly liquid Global mid and large-cap Brand companies, listed on exchanges in developed countries. The program invests exclusively in the consumer, technology and healthcare space. Fundamental, market and sentiment factor data are used to pick the underlying stocks, which are then combined to a portfolio using portfolio construction techniques, including artificial intelligence.
A protective cash buffer (enhanced Beta) can be raised during periods of overall market uncertainty (up to 100% cash).
In a favourable stock picking environment, leverage (0-100%) can be added to the long portfolio (Alpha), and the leverage is hedged with an equal size index short. In expected weak stock picking environment, the exposure can be geared down.
We see persistent structural anomalies in the market due to heterogeneous utility function of people (behavioural finance). Although the anomalies persist, they will change over time (some will only work at a certain period) and that is why we have our own machine learning algorithm that dynamically allocates weights to different factors.
Compared to most peers we use a 100% systematic approach and can process millions of data points. The factor allocation process including machine learning is another unique aspect as is the feature of increasing the allocation (up to two times) to the core portfolio (while hedging the additional exposure) and the feature of going partially or totally into cash in certain market environments. All features are based on quantitative analysis of the portfolio and the macro environment.
The objective of the is to use Premiere investment technology and experience in order to generate a sustainable and robust long term capital growth, independent of economic cycles and stock market upheavals.
Q Brands pursues a long-biased investment style which is systematic, investing globally in highly liquid Global mid and large-cap Brand companies, listed on exchanges in developed countries
100% systematic approach and can process millions of data points. The factor allocation process including machine learning is another unique aspect as is the feature of increasing the allocation (up to two times) to the core portfolio (while hedging the additional exposure) and the feature of going partially or totally into cash in certain market environments
Sustainable and robust long-term capital growth, independent of economic cycles and stock market upheavals
ML Capital Asset Management Ltd, 23 St. Stephen's Green, Dublin 2, D02 AR55, Ireland is licensed to provide Investment Management services to Professional Clients (including Collective Investment Schemes) by the Central Bank of Ireland.
MontLake UCITS Platform ICAV is an umbrella open-ended Irish collective asset-management vehicle with segregated liability between Funds formed in Ireland under the Irish Collective Asset-management Vehicles Act 2015 and authorised by the Central Bank as a UCITS pursuant to the UCITS Regulations.
The Manager of MontLake UCITS Platform ICAV is MLC Management Ltd, a company regulated by the Central Bank of Ireland.
This website is directed mainly for professional and institutional clients who possess the necessary experience, knowledge and expertise to make their own investment decisions and properly assess the risk that it incurs.
Information on this website was obtained from various sources and the company does not guarantee its accuracy. The information is for your private use and discussion purposes only and expressed views and opinions may change.
The Performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. The value of your investment and their income may go down as well as up.
Your investment may also be subject to currency, interest rate, as well as market fluctuations. Consequently the Investor may not get back a sum equal to that he / she originally invested.
Investors should note that an investment in those Sub-Funds which may invest in emerging markets should not constitute a substantial proportion of an investment portfolio and may not be appropriate for all investors.
The Sub-Funds may invest in Over the Counter as well as Exchange Traded derivative instruments to enhance return or hedge against fluctuations in security prices or market rates as well as to short sell a security through the use of a derivative instrument. Transactions in derivative instruments involve a risk of loss or depreciation of capital due to adverse changes in security prices, exchange rates or interest rates or in the case of OTC instruments default of Counterparty. This investment may not be suitable for all types of investors. It is therefore recommended that you consult your investment advisor.
A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. The Investment Manager will be entitled to receive a performance fee as well as a management fee, calculated on a daily basis and paid quarterly by the sub-funds.
The Levels and bases of taxation are dependent on individual circumstances and subject to change and therefore it is highly recommended that you consult a professional tax advisor.